RÉSUMÉ
The Forkhead box protein M1 (FoxM1) is an appealing target for anti-cancer therapeutics as this cell proliferation-associated transcription factor is overexpressed in most human cancers. FoxM1 is involved in tumor invasion, angiogenesis, and metastasis. To discover novel inhibitors that disrupt the FoxM1-DNA interaction, we identified CDI, a small molecule that inhibits the FoxM1-DNA interaction. CDI was identified through an assay based on the time-resolved fluorescence energy transfer response of a labeled consensus oligonucleotide that was bound to a recombinant FoxM1-dsDNA binding domain (FoxM1-DBD) protein and exhibited potent inhibitory activity against FoxM1-DNA interaction. CDI suppressed cell proliferation and induced apoptosis in MDA-MB-231 cells obtained from a breast cancer patient. Furthermore, it decreased not only the mRNA and protein expression of FoxM1 but also that of downstream targets such as CDC25b. Additionally, global transcript profiling of MDA-MB-231 cells by RNA-Seq showed that CDI decreases the expression of FoxM1-regulated genes. The docking and MD simulation results indicated that CDI likely binds to the DNA interaction site of FoxM1-DBD and inhibits the function of FoxM1-DBD. These results of CDI being a possible effective inhibitor of FoxM1-DNA interaction will encourage its usage in pharmaceutical applications.
RÉSUMÉ
Electrophoretic mobility shift assay (EMSA) technology has been widely employed for the analysis of transcription factors such as Forkhead box protein M1 (FOXM1). However, the application of high-throughput screening (HTS) in performing, such analyses are limited as it uses time consuming electrophoresis procedure and radioisotopes. In this study, we developed a FOXM1-DNA binding domain (DBD) binding assay based on time-resolved fluorescence energy transfer (TR-FRET) that enables HTS for the inhibitors of FOXM1-DNA interaction. This assay was robust, highly reproducible and could be easily miniaturized into 384-well plate format. The signal-to-background (S/B) ratio and Z' factor were calculated as 7.46 and 0.74, respectively, via a series of optimization of the assay conditions. A pilot library screening of 1019 natural compounds was performed using the FOXM1-DBD binding assay. Five hit compounds, namely, AC1LXM, BRN5, gangaleoidin, leoidin, and roemerine were identified as the inhibitors of FOXM1. In a cell viability assay, it was demonstrated that cell proliferation of FOXM1 overexpressed cell lines was suppressed in cell lines such as MDA-MB-231 and MCF-7 by five hit compounds. These results indicate that developed FOXM1-DBD binding assay can be applied to highly efficiency HTS of compound libraries.
Sujet(s)
Protéine M1 à motif en tête de fourche/métabolisme , Tests de criblage à haut débit/méthodes , ADN/métabolisme , Découverte de médicament/méthodes , Transfert d'énergie par résonance de fluorescence , Protéine M1 à motif en tête de fourche/antagonistes et inhibiteurs , Humains , Cellules MCF-7 , Liaison aux protéines/effets des médicaments et des substances chimiques , Motifs et domaines d'intéraction protéiqueRÉSUMÉ
This study was conducted to investigate the yield and quality characteristics of red bean sprouts of three cultivars (Arari, Geomguseul, and Chungju) soaked in water for 0, 6, 12 or 24 h. The sprout yields of 'Arari' and 'Geomguseul' on day 7 were highest with the seeds soaked for 12 h. For 'Chungju', the yields from the seeds soaked for 12 and 24 h were not significantly (p > 0.05) different. Longer hypocotyls and shorter roots, which are also desirable characteristics of good sprouts, were also found in the sprouts with 12 h of seed soaking. The amounts of total minerals, thiamine, total free amino acids, and total phenols and DPPH radical scavenging potential of sprouts of all cultivars were higher than those of their seeds. This study showed that higher yield and better quality of red bean sprouts could be obtained with the seeds soaked for 12 h.
RÉSUMÉ
CASE SUMMARY: A 9-year-old male neutered domestic shorthair cat presented with anorexia. Ultrasonography showed an irregularly shaped hypoechoic mass in the cranial pole of the right kidney. Ultrasound-guided fine-needle aspiration of the renal mass was performed. Cytology revealed moderate cellularity smears composed of epithelial cell clusters, which consisted of an exclusive population of oncocytic cells seen in sheets and papillary clusters along with abundant single cells. A moderate-to-abundant amount of densely stained granular cytoplasm with round nuclei and indistinct nucleoli was seen. The cytological diagnosis was renal oncocytic neoplasm. CT and surgical resection revealed a firm tan mass in the right kidney. A final diagnosis of renal oncocytoma was made on the basis of histology, immunohistochemical staining profile (positive for cytokeratin, and negative for chromogranin A, neuron-specific enolase and vimentin) of neoplastic cells, together with the electronic microscopy results. RELEVANCE AND NOVEL INFORMATION: We believe that this is the first report of the cytological features of feline renal oncocytoma.
RÉSUMÉ
The popular screening method for urotensin (UT) receptor antagonists is to measure the intracellular calcium concentration with a calcium-sensitive fluorescent dye. This assay format has an inherent limitation on the problem related to the fluorescence interference as it involves fluorescent dyes. In the present study, a label-free assay for the screening of UT receptor antagonists was developed by using dynamic mass redistribution (DMR) assay based on label-free optical biosensor. The addition of urotensin II (UII) stimulated a DMR profile to HEK293 cells stably expressing the human UT receptor (HEK293UT cells) but not on parental cells. The EC50 value of UII in label-free assay was 4.58 nM, which is very similar to that in conventional calcium mobilization assay (4.15 nM). Compared with the calcium mobilization assay for UII (Z' factor, 0.77), the current label-free assay presented improved Z' factor (0.81), with a relatively similar S/B ratio (28.0 and 25.6, respectively). The known high-affinity UT receptor antagonists, SB657510, GSK562590, and urantide, exhibited comparable IC50 values but rather less potent in the DMR assay than in calcium mobilization. Our DMR assay was able to present various functional responses, including inverse agonism in SB657510 and GSK1562590 as well as partial agonism in urantide. Moreover, the DMR assay exerted the stable antagonist window upon the minimal agonist stimulus. These results suggest that the label-free cell-based UT receptor assay can be applicable to evaluate the various functional activities of UT receptor-related drug candidates.
Sujet(s)
Calcium/métabolisme , Récepteurs couplés aux protéines G/analyse , Récepteurs couplés aux protéines G/métabolisme , Spectrométrie de fluorescence/méthodes , Colorants fluorescents/analyse , Cellules HEK293 , Humains , Récepteurs couplés aux protéines G/agonistes , Urotensines/analyse , Urotensines/métabolismeRÉSUMÉ
Kamolonol (7-[[(1R,2R,4R,4aS,5R,8aS)-4-hydroxy-1,2,4a,5-tetramethyl-6-oxo-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]chromen-2-one) is a sesquiterpene coumarin and an active component of gum extracts from Ferulaassafoetida. The aim of this study was to investigate the anti-fibrotic and anti-cellular hypertrophic effects of kamolonol, and further to explore its possible mechanism. Kamolonol (3-30µM) significantly inhibited stress fiber formation induced by angiotensin II (Ang II) in rat heart-derived H9c2 cells. Furthermore, kamolonol (3-30µM) showed a potent inhibitory effect on Ang II-induced cellular hypertrophy in H9c2 cells. Next, a Rho-associated kinase (ROCK) activity was measured because actin stress fiber formation and/or cellular hypertrophy are usually induced by the activation of ROCK. Rho-associated kinase 2 (ROCK2) studies using a time-resolved fluorescence resonance energy transfer (TR-FRET) showed that kamolonol possesses a potent ROCK2 inhibitory activity with IC50 values of 2.27µM, and has an ATP-competitive inhibitory mode. In validation study, pretreatment of kamolonol (3-30µM) for 2h decreased the Ang II-induced phosphorylation of myosin phosphatase 1 (MYPT1) and myosin light chain 2 (MLC2). Taken together, these results indicate that kamolonol suppresses Ang II-induced stress fiber formation and cellular hypertrophy, and propose that one mechanism underlying these anti-fibrotic and anti-cellular hypertrophic effects involves inhibition of the ROCK-MLC pathway.
Sujet(s)
Angiotensine-II/métabolisme , Coumarines/pharmacologie , Régulation de l'expression des gènes codant pour des enzymes , Sesquiterpènes/pharmacologie , Fibres de stress/métabolisme , rho-Associated Kinases/métabolisme , Animaux , Lignée cellulaire , Relation dose-effet des médicaments , Humains , Hypertrophie , Concentration inhibitrice 50 , Phosphorylation , RatsRÉSUMÉ
Recent advances in basic and clinical studies have identified Rho kinase (ROCK) as an important target potentially implicated in a variety of cardiovascular diseases and ROCK inhibitors were considered as a pharmacological strategy to prevent and treat cardiovascular diseases. To screen the small molecule compound library against ROCK, a high throughput screening (HTS) campaign was carried out using immobilized metal affinity for phosphochemicals (IMAP)-based time-resolved fluorescence resonance energy transfer (TR-FRET) assay. Z' value and signal to background (S/B) ratio were achieved at 0.76 and 5.27 for the pilot library screening of the most diverse set consisting of 15,040 compounds with a reasonable reconfirmation rate. From this screening campaign, four novel scaffolds, such as 3- nitropyridine, 4-methoxy-1,3,5,-triazine, naphthalene-1,4-dione, and 2,3-dihydro-1H-pyrrolo[2,3-b]quinoxaline, were yielded. Particularly, we found that 3-nitropyridine derivatives possess potent inhibitory activity and selectivity for ROCK. Our findings provide important information for the design of novel ROCK inhibitor.
Sujet(s)
Évaluation préclinique de médicament/méthodes , Tests de criblage à haut débit/méthodes , Inhibiteurs de protéines kinases/composition chimique , Inhibiteurs de protéines kinases/pharmacologie , Bibliothèques de petites molécules/composition chimique , Bibliothèques de petites molécules/pharmacologie , rho-Associated Kinases/antagonistes et inhibiteurs , Conception de médicament , Humains , Modèles moléculaires , rho-Associated Kinases/métabolismeRÉSUMÉ
Baicalein is a flavonoid (5,6,7-trihydroxy-2-phenyl-4H-1-benzopyran4-one) and an active principle in Scutellaria baicalensis. The present study was performed to investigate the mechanisms underlying the anti-fibrotic effects of baicalein with a focus on Rho kinase (ROCK) inhibition. The effect of baicalein on ROCK activity was analyzed using an immobilized metal affinity for phosphochemicals (IMAP)-based time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The underlying mechanisms of baicalein were examined using angiotensin II-stimulated H9c2 cells. Rho kinase (ROCK1 and ROCK2) studies using IMAP-TR-FRET showed that baicalein possesses potent ROCK inhibitory activity with IC50 values of 6.55 and 2.82 µM, respectively. Pretreatment with baicalein (for 2 h) concentration-dependently decreased the angiotensin II-induced phosphorylation of myosin phosphatase (MYPT) and myosin light chain (MLC). Furthermore, baicalein also concentration-dependently suppressed actin stress fiber formation in angiotensin II-stimulated H9c2 cells. These results suggest that baicalein potently inhibits ROCK and that by so doing it modulates actin stress fiber formation. These anti-fibrotic effects of baicalein explain, at least in part, its pharmacology and mode of action.
Sujet(s)
Actines/métabolisme , Angiotensine-II/pharmacologie , Flavanones/pharmacologie , Extraits de plantes/pharmacologie , Scutellaria baicalensis/composition chimique , Fibres de stress/effets des médicaments et des substances chimiques , rho-Associated Kinases/antagonistes et inhibiteurs , Animaux , Lignée cellulaire , Relation dose-effet des médicaments , Fibrose/métabolisme , Fibrose/prévention et contrôle , Flavanones/usage thérapeutique , Concentration inhibitrice 50 , Chaînes légères de myosine/métabolisme , Myosin-light-chain phosphatase/métabolisme , Phosphorylation , Phytothérapie , Extraits de plantes/usage thérapeutique , Rats , Fibres de stress/métabolisme , Fibres de stress/anatomopathologie , Vasoconstricteurs/pharmacologieRÉSUMÉ
Salvianolic acid A, an active compound present in Salvia miltiorrhiza, is a phenolic carboxylic acid derivative, ((2R)-3-(3,4-Dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl) ethenyl]-3,4-dihydroxyphenyl] prop-2-enoyl]oxypropanoic acid). The present study was performed to investigate the underlying mechanisms of anti-inflammatory effects with salvianolic acid A, specially focused on nuclear factor κB (NF-κB) signaling pathway by targeting the IκB kinase ß (IKKß). The effect of salvianolic acid A for IKKß activity was analyzed using an immobilized metal affinity for phosphochemicals (IMAP)-based time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The underlying mechanisms of salvianolic acid A were examined using lipopolysaccharide (LPS)-stimulated RAW264.7 cells. IKKß studies based on IMAP-TR-FRET showed that salvianolic acid A possesses a potent IKKß inhibitory activity with Ki value of 3.63 µM in an ATP-noncompetitive manner. Pretreatment with salvianolic acid A (10, 30 µM) decreased LPS-induced expression of iNOS and COX-2, thereby inhibiting production of nitric oxide and prostaglandin E(2), respectively. In addition, salvianolic acid A (10, 30 µM) also attenuated the LPS-induced IκBα phosphorylation and degradation, and NF-κB translocation. These results suggest that salvianolic acid A modulates NF-κB-dependent inflammatory pathways through IKKß inhibition and these anti-inflammatory effects will aid in understanding the pharmacology and mode of action of salvianolic acid A.
Sujet(s)
Anti-inflammatoires non stéroïdiens/pharmacologie , Acides caféiques/pharmacocinétique , I-kappa B Kinase/antagonistes et inhibiteurs , Lactates/pharmacocinétique , Lipopolysaccharides/pharmacologie , Facteur de transcription NF-kappa B/métabolisme , Animaux , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Cyclooxygenase 2/métabolisme , Dinoprostone/métabolisme , Transfert d'énergie par résonance de fluorescence , Immunotransfert , Macrophages/effets des médicaments et des substances chimiques , Macrophages/enzymologie , Macrophages/métabolisme , Souris , Microscopie de fluorescence , Structure moléculaire , Nitric oxide synthase type II/métabolisme , Nitrites/métabolismeRÉSUMÉ
AIM OF THE STUDY: The present study was performed to investigate the underlying mechanisms of anti-inflammatory effects with the extract of Euonymus alatus (EEA), and specially focused on nuclear factor κB (NF-κB) signaling pathway by targeting the IκB kinase ß (IKKß). MATERIALS AND METHODS: The effect of EEA for IKKß activity was analyzed using an immobilized metal affinity for phosphochemicals (IMAP)-based time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The effect of EEA on lipopolysaccharide (LPS)-induced NF-κB activation in murine macrophage RAW 264.7 cells with western blotting and immunofluorescent staining was evaluated. RESULTS: IKKß studies based on IMAP-TR-FRET showed that EEA possesses a potent IKKß inhibitory activity with IC(50) value of 11.83µg/ml. EEA (10, 30µg/ml) also attenuated the LPS-induced IκBα phosphorylation/degradation, NF-κB translocation and subsequent NO synthesis in RAW 264.7 cells. CONCLUSIONS: These results suggest that EEA abrogates LPS-induced NF-κB signaling pathway by targeting the IKKß in RAW 264.7 cells and these properties may provide a molecular basis for understanding the inhibitory effects of EEA on LPS-mediated inflammation.
Sujet(s)
Anti-inflammatoires/pharmacologie , Euonymus , I-kappa B Kinase/antagonistes et inhibiteurs , Macrophages/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/métabolisme , Extraits de plantes/pharmacologie , Animaux , Anti-inflammatoires/usage thérapeutique , Transport biologique/effets des médicaments et des substances chimiques , Inflammation/traitement médicamenteux , Concentration inhibitrice 50 , Lipopolysaccharides/pharmacologie , Macrophages/métabolisme , Souris , Monoxyde d'azote/biosynthèse , Phosphorylation , Phytothérapie , Extraits de plantes/usage thérapeutique , Transduction du signal/effets des médicaments et des substances chimiquesRÉSUMÉ
It has been known that ethanol causes neuronal cell death through oxidative stress. Ethanol itself and reactive oxygen species (ROS) produced by ethanol modulate intracellular signaling pathways including mitogen-activated protein kinase (MAPK) cascades. This study was conducted to examine the impact of ethanol on MAPK signaling in HT22 cells. Ethanol (100 and 400mM) caused activation of ERK, p38 MAPK, and JNK. ERK activation occurred in early time and p38 MAPK activation was evident when ERK activation was diminished. Specific inhibitor of p38 MAPK (SB203580) protected HT22 cells against ethanol, which was accompanied by an inhibition of ROS accumulation. However, inhibitors of ERK (U0126) and JNK (SP600125) had no effects on ethanol-induced neuronal cell death when they are treated with ethanol for 24h. These results suggest that p38 MAPK may have important roles in ROS accumulation during ethanol-induced oxidative stress in HT22 cells.
Sujet(s)
Dépresseurs du système nerveux central/pharmacologie , Éthanol/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Transduction du signal/physiologie , p38 Mitogen-Activated Protein Kinases/métabolisme , Animaux , Lignée de cellules transformées , Survie cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Interactions médicamenteuses , Antienzymes/pharmacologie , Souris , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
Acute alcohol ingestion is well known to have deleterious effects on memory and also known to inhibit long-term potentiation, a putative cellular substrate of memory. In this study, we for the first time revealed that growth-associated protein 43 (GAP-43), which is well known as a presynaptic substrate of protein kinase C and one of the major synaptic plasticity-related genes, was down regulated by single ethanol administration (2.5 g/kg, 15% in saline, i.p.) in the rat hippocampus. Using real-time PCR, we confirmed that GAP-43 mRNA level is significantly decreased 2 h after ethanol administration. GAP-43 and p-GAP-43 (Ser41) immunoreactivities in the hippocampus were also reduced 4 h after ethanol administration. Immunohistochemical study showed that the reduction of GAP-43 and p-GAP-43 expression was associated with the perforant and mossy fibers pathways. These results suggest that the reduction of GAP-43 in the hippocampus might be, at least in part, a cause of memory impairment after acute ethanol ingestion.
Sujet(s)
Dépresseurs du système nerveux central/administration et posologie , Éthanol/administration et posologie , Protéine GAP-43/métabolisme , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Technique de Western/méthodes , Dépresseurs du système nerveux central/sang , Éthanol/sang , Protéine GAP-43/génétique , Immunohistochimie/méthodes , Mâle , Phosphorylation/effets des médicaments et des substances chimiques , Protéine kinase C/métabolisme , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , Facteurs tempsRÉSUMÉ
Ethanol has deleterious effects on neuronal cells both in vivo and in vitro, but the mechanisms are unknown. Here, treatment with increasing doses of ethanol (from 20 up to 600mM) decreased the viability of a mouse hippocampal neuroblastoma cell line, HT22. The glutathione concentration decreased and intracellular reactive oxygen species (ROS) increased in a dose-and time-dependent manner, suggesting that the neurotoxicity was due to oxidative stress. Expression of heme oxygenase (HO)-1, a redox regulator and heat shock protein, increased with time after ethanol treatment, but HO-2 was expressed constitutively. The addition of 5microM zinc protoporphyrin IX (ZnPP IX), a competitive HO inhibitor, with the ethanol further reduced cell viability and increased intracellular ROS, but these effects were reversed by co-treatment with 50nM bilirubin, a well-known antioxidant and a product of HO catalysis. These results suggest that HO has a protective role in hippocampal neurons as an intrinsic factor against ethanol-induced oxidative stress and the protection depends on the degree of oxidative stress.